Telmigreat-AMH Tablet
Marketer
Nunchi Pharma Pvt. Ltd.
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmigreat-AMH Tablet
Amlodipine/Hydrochlorothiazide tablets are a dual-action medication prescribed for managing hypertension when monotherapy proves insufficient. This combination lowers elevated blood pressure, significantly reducing the risk of future strokes and heart attacks. The medication can be administered with or without food, with dosage tailored to individual response and health status. Consistent daily timing is recommended. Continuous use, as directed by your physician, is crucial. The diuretic component may increase urination; therefore, avoid late-evening dosing (within four hours of bedtime). Regular use, even during symptom-free periods, is vital for optimal efficacy. Hypertension often lacks noticeable symptoms, and discontinuation elevates the risk of cardiovascular events. Common side effects may include headaches, lightheadedness, lethargy, altered taste perception, fatigue, influenza-like symptoms, diarrhea, and sinus inflammation. Report any persistent, worsening, or troublesome side effects to your doctor. Adequate hydration is recommended to mitigate potential side effects such as muscle weakness, dry mouth, and excessive thirst. Prior to commencing treatment, inform your doctor of any pre-existing kidney or liver conditions. Pregnant or lactating individuals should seek medical counsel before use. Comprehensive disclosure of all current medications, particularly those for hypertension or cardiac conditions, is necessary. Regular monitoring of blood pressure, kidney function, electrolyte balance, and blood glucose levels is essential to ensure therapeutic effectiveness and safety.
Uses of Telmigreat-AMH Tablet
Elevated arterial blood pressure
Major Benefits of Telmigreat-AMH Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmigreat-AMH Tablet whole; do not alter its form by chewing, crushing, or breaking. It can be taken with or without food, though consistent timing is recommended.
Common Side effects of Telmigreat-AMH Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmigreat-AMH Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Telmigreat-AMH Tablets can be administered with or without food, although consistent timing is recommended.
How Telmigreat-AMH Tablet works:
Telmisartan, Amlodipine, and Hydrochlorothiazide, combined in Telmigreat-AMH tablets, offer a three-pronged approach to hypertension management. Telmisartan, an angiotensin receptor blocker (ARB), and Amlodipine, a calcium channel blocker (CCB), act synergistically to dilate blood vessels, thus reducing blood pressure. Hydrochlorothiazide, a diuretic, complements this action by promoting fluid excretion and electrolyte balance, further enhancing vasodilation and improving circulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Telmigreat-AMH Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Telmigreat-AMH Tablets during pregnancy poses a known risk to the fetus. Therefore, it's not recommended. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the acknowledged dangers. Always seek medical advice.
Breast feedingUNSAFE
The use of Telmigreat-AMH tablets while breastfeeding is contraindicated due to potential infant toxicity. Research indicates a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Driving may be impaired by Telmigreat-AMH Tablet side effects. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and driving ability.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmigreat-AMH Tablets, as dose modification may be necessary. Physician consultation is advised. Telmigreat-AMH Tablets are contraindicated in patients with severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should use Telmigreat-AMH Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telmigreat-AMH Tablet :
Should you forget a Telmigreat-AMH Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmigreat-AMH Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |




